John Rim, Samsung Biologics CEO

Sam­sung Bi­o­log­ics moves up plans to open its $1.5B+ plant

Sam­sung Bi­o­log­ics, the con­tract man­u­fac­tur­ing arm of the South Ko­re­an-based con­glom­er­ate Sam­sung, plans to open the doors to one of its fac­to­ries a lit­tle soon­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.